<i>In vitro</i> modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant <i>EGFR</i> mutants in non-small-cell lung cancerToshiyuki Hirano, Kenzo Soejima, Hiroyuki Yasuda et al.|Oncotarget|2015Cited by 159
Social impact of brain fog and analysis of risk factors: Long <scp>COVID</scp> in Japanese populationLisa Shigematsu, Koichi Fukunaga, Shogyoku Bun et al.|Annals of Clinical and Translational Neurology|2024Cited by 9
Chronic obstructive pulmonary disease, asthma, and mechanical ventilation are risk factors for dyspnea in patients with long COVID: A Japanese nationwide cohort studyEmiko Matsuyama, Koichi Fukunaga, Jun Miyata et al.|Respiratory Investigation|2024Cited by 4
Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with CetuximabAyano Oashi, Kenzo Soejima, Hiroyuki Yasuda et al.|Molecular Cancer Therapeutics|2019Cited by 4
Data from Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with CetuximabAyano Oashi, Kenzo Soejima, Hiroyuki Yasuda et al.|Unknown|2023Cited by 0